Litcius/Paper detail

Use of the oral Janus kinase inhibitor tofacitinib in the treatment of morphea: A retrospective study

Mahshid Sadat Ansari, Seyed Mohammad Vahabi, Huria Memari, Hosseini Agha Fatemeh, Saeed Bahramian, Ifa Etesami

2025Journal of the American Academy of Dermatology8 citationsDOI

Topics & Concepts

TofacitinibMedicineMorpheaDermatologyJanus kinase inhibitorRetrospective cohort studyInternal medicineRheumatoid arthritisLichen sclerosusSystemic Sclerosis and Related DiseasesAutoimmune Bullous Skin DiseasesUrticaria and Related Conditions
Use of the oral Janus kinase inhibitor tofacitinib in the treatment of morphea: A retrospective study | Litcius